Proven Patient-Pleasing Relief

For patients who are frustrated by allergy symptoms including nasal congestion

No 2 allergy patients are alike. For those who need the most effective class of nasal allergy medication,1 Nasacort Allergy 24HR delivers proven efficacy without an unpleasant scent, alcohol, or harsh taste. Nasacort treats both early- and late-phase AR symptoms—including nasal congestion—by treating the inflammation associated with allergic rhinitis.2

*See Drug Facts label. Use as directed.

Product
 
 
 
 
PROVEN RELIEF

Clinically proven to be as effective as Flonase

Single-blind, randomized, parallel-group study of Flonase (200 μg/day, n=147) vs Nasacort AQ (220 μg/day, n=148) in patients with seasonal rhinitis.3

New-Line-graph

aTotal nasal symptom score is the sum of scores for nasal stuffiness, nasal discharge, nasal itching, and sneezing.

bNeither treatment group was statistically significant vs the other at any time interval during the entire treatment period.

References: 1. Wallace DV, Dykewicz MS, Bernstein DI, et al; Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(suppl 2):S1-S84 2. Luskin AT, Scherger JE, Pollart SM. Beyond the nose: the systemic inflammatory effects of allergic rhinitis. Hosp Physician. 2004;40(2):13-22. 3. Berger WE, Kaiser H, Gawchik SM, et al. Triamcinolone acetonide aqueous nasal spray and fluticasone propionate are equally effective for relief of nasal symptoms in patients with seasonal allergic rhinitis. Otolaryngol Head Neck Surg. 2003;129(1):16-23.

Close
Footnotes & References

Symptom relief as early as day 1

A randomized, placebo-controlled, double-blind, 3-week study to investigate the efficacy and safety of once-daily Nasacort AQ. Symptom severity of each individual component of the nasal index was assessed on a scale from 0 (absent) to 3 (severe). Patients randomized to the Nasacort AQ group received 220 mcg/day for the first week of treatment and either 220 mcg/day (n=145) or 110 mcg/day (n=142) for the remainder of the study; 142 patients received placebo.4

clinical-study-chart3

*It may take up to 1 week of daily use to feel the most symptom relief.

aMeasured before second dose.

bMeasured over the last 2-week (post-titration) periods.

cNasal index is the sum of congestion, nasal discharge, and sneezing.

References: 4. Settipane G, Korenblat PE, Winder J, et al. Triamcinolone acetonide aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study. Clin Ther. 1995;17(2):252-263. 5. Data on file. Sanofi‑aventis U.S.

Close
Footnotes & References
PATIENT-PLEASING

A difference patients can feel

Nasacort is a patient-pleasing nasal spray

Small Table

Unlike Flonase, Nasacort is scent- and alcohol-free6

A scent-free, alcohol-free option may be important for your patients.

Reference: 6. GlaxoSmithKline. Flonase Allergy Relief Question and Answer Book. Clifton, NJ: GlaxoSmithKline; 2014.

Close
Footnotes & References

Stays where it’s sprayed

Nasacort’s thixotropic formulation contains hydrophilic, high-viscosity solution that adheres to the nasal mucosa,7 which:

  • Allows for contact time with glucocorticoid receptors
  • Resists unwanted clearance from the nasal passages

Reference: 7. Koz‘min‘ski M, Kupczyk M. Thixotropy of nasal medications—its role in clinical practice. Pneumonol Alergol Pol. 2015;83:157-163.

Close
Footnotes & References